Profile
Andrew King worked as a Senior Director of Discovery & Translational Biology at Ardelyx, Inc. He then served as the Chief Scientific Officer at Chinook Therapeutics, Inc. from 2021 to 2023.
Dr. King holds a doctorate degree from Michigan State University and an undergraduate degree from Murdoch University.
Former positions of Andrew King
| Companies | Position | End |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 08/08/2023 |
| ARDELYX, INC. | Corporate Officer/Principal | - |
Training of Andrew King
| Murdoch University | Undergraduate Degree |
| Michigan State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ARDELYX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Andrew King
